This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Analytica Past Earnings Performance

Past criteria checks 0/6

Analytica has been growing earnings at an average annual rate of 5.5%, while the Medical Equipment industry saw earnings growing at 4.7% annually. Revenues have been declining at an average rate of 16.5% per year.

Key information

5.5%

Earnings growth rate

18.6%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate-16.5%
Return on equityn/a
Net Margin-687.1%
Last Earnings Update31 Dec 2022

Recent past performance updates

Recent updates

Does Analytica's (ASX:ALT) CEO Salary Compare Well With The Performance Of The Company?

Dec 24
Does Analytica's (ASX:ALT) CEO Salary Compare Well With The Performance Of The Company?

Revenue & Expenses Breakdown
Beta

How Analytica makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:ALT Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 220-210
30 Sep 220-210
30 Jun 220-210
31 Mar 220-210
31 Dec 210-210
30 Sep 210-210
30 Jun 211-210
31 Mar 211-210
31 Dec 201-210
30 Sep 201-210
30 Jun 201-210
31 Mar 201-110
31 Dec 192-110
30 Sep 191-210
30 Jun 191-210
31 Mar 191-210
31 Dec 181-210
30 Sep 181-210
30 Jun 181-210
31 Mar 181-320
31 Dec 170-420
30 Sep 171-420
30 Jun 171-320
31 Mar 171-320
31 Dec 161-420
30 Sep 162-430
30 Jun 162-430
31 Mar 162-430
31 Dec 152-530
30 Sep 152-530
30 Jun 151-530
31 Mar 151-520
31 Dec 142-420
30 Sep 141-320
30 Jun 141-310
31 Mar 141-210
31 Dec 131-210
30 Sep 131-110
30 Jun 131-100
31 Mar 130-100
31 Dec 120-101
30 Sep 120-201
30 Jun 120-201

Quality Earnings: ALT is currently unprofitable.

Growing Profit Margin: ALT is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALT is unprofitable, but has reduced losses over the past 5 years at a rate of 5.5% per year.

Accelerating Growth: Unable to compare ALT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.9%).


Return on Equity

High ROE: ALT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.